Theravance Biopharma TBPH Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $835.73M.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's market capitalization?
- Theravance Biopharma (TBPH) reported market capitalization of $835.73M in Q1 2026.
- How has Theravance Biopharma's market capitalization changed year-over-year?
- Theravance Biopharma's market capitalization increased by 89.2% year-over-year, from $441.77M to $835.73M.
- What is the long-term trend for Theravance Biopharma's market capitalization?
- Over 5 years (2020 to 2025), Theravance Biopharma's market capitalization has grown at a -3.7% compound annual growth rate (CAGR), from $1.15B to $948.08M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.